248 related articles for article (PubMed ID: 29508411)
1. Proton pump inhibitor use and risk of hip fractures among community-dwelling persons with Alzheimer's disease-a nested case-control study.
Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Aliment Pharmacol Ther; 2018 Apr; 47(8):1135-1142. PubMed ID: 29508411
[TBL] [Abstract][Full Text] [Related]
2. Long-term thiazide use and risk of low-energy fractures among persons with Alzheimer's disease-nested case-control study.
Taipale H; Rysä J; Hukkanen J; Koponen M; Tanskanen A; Tiihonen J; Kröger H; Hartikainen S; Tolppanen AM
Osteoporos Int; 2019 Jul; 30(7):1481-1489. PubMed ID: 30993395
[TBL] [Abstract][Full Text] [Related]
3. Proton-pump inhibitor use and hip fractures in men: a population-based case-control study.
Adams AL; Black MH; Zhang JL; Shi JM; Jacobsen SJ
Ann Epidemiol; 2014 Apr; 24(4):286-90. PubMed ID: 24507954
[TBL] [Abstract][Full Text] [Related]
4. Long-term proton pump inhibitor therapy and risk of hip fracture.
Yang YX; Lewis JD; Epstein S; Metz DC
JAMA; 2006 Dec; 296(24):2947-53. PubMed ID: 17190895
[TBL] [Abstract][Full Text] [Related]
5. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients.
Lenihan CR; Sukumaran Nair S; Vangala C; Ramanathan V; Montez-Rath ME; Winkelmayer WC
Am J Kidney Dis; 2017 May; 69(5):595-601. PubMed ID: 27866965
[TBL] [Abstract][Full Text] [Related]
6. Incident Use of a Potentially Inappropriate Medication and Hip Fracture in Community-Dwelling Older Persons With Alzheimer's Disease.
Hyttinen V; Taipale H; Tolppanen AM; Tanskanen A; Tiihonen J; Hartikainen S; Valtonen H
Ann Pharmacother; 2017 Sep; 51(9):725-734. PubMed ID: 28486815
[TBL] [Abstract][Full Text] [Related]
7. Use of proton pump inhibitors and risk of fragility hip fracture in a Mediterranean region.
Reyes C; Formiga F; Coderch M; Hoyo J; Ferriz G; Casanovas J; Monteserín R; Brotons C; Rojas M; Moral I
Bone; 2013 Feb; 52(2):557-61. PubMed ID: 23023097
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease.
Koponen M; Taipale H; Lavikainen P; Tanskanen A; Tiihonen J; Tolppanen AM; Ahonen R; Hartikainen S
J Clin Psychiatry; 2017 Mar; 78(3):e257-e263. PubMed ID: 28146612
[TBL] [Abstract][Full Text] [Related]
9. No Association Between Proton Pump Inhibitor Use and Risk of Alzheimer's Disease.
Taipale H; Tolppanen AM; Tiihonen M; Tanskanen A; Tiihonen J; Hartikainen S
Am J Gastroenterol; 2017 Dec; 112(12):1802-1808. PubMed ID: 28695906
[TBL] [Abstract][Full Text] [Related]
10. Incident hip fractures among community dwelling persons with Alzheimer's disease in a Finnish nationwide register-based cohort.
Tolppanen AM; Lavikainen P; Soininen H; Hartikainen S
PLoS One; 2013; 8(3):e59124. PubMed ID: 23527106
[TBL] [Abstract][Full Text] [Related]
11. Proton pump inhibitor use and risk of hip fractures in patients without major risk factors.
Kaye JA; Jick H
Pharmacotherapy; 2008 Aug; 28(8):951-9. PubMed ID: 18657011
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and histamine-2 receptor antagonists are associated with hip fractures among at-risk patients.
Corley DA; Kubo A; Zhao W; Quesenberry C
Gastroenterology; 2010 Jul; 139(1):93-101. PubMed ID: 20353792
[TBL] [Abstract][Full Text] [Related]
13. Comparison of predictors of hip fracture and mortality after hip fracture in community-dwellers with and without Alzheimer's disease - exposure-matched cohort study.
Tolppanen AM; Taipale H; Tanskanen A; Tiihonen J; Hartikainen S
BMC Geriatr; 2016 Dec; 16(1):204. PubMed ID: 27908278
[TBL] [Abstract][Full Text] [Related]
14. Long-term use of proton pump inhibitors among community-dwelling persons with and without Alzheimer's disease.
Juntunen H; Taipale H; Tanskanen A; Tolppanen AM; Tiihonen J; Hartikainen S; Tiihonen M
Eur J Clin Pharmacol; 2017 Sep; 73(9):1149-1158. PubMed ID: 28577224
[TBL] [Abstract][Full Text] [Related]
15. Antidepressant use and risk of hip fractures among community-dwelling persons with and without Alzheimer's disease.
Torvinen-Kiiskinen S; Tolppanen AM; Koponen M; Tanskanen A; Tiihonen J; Hartikainen S; Taipale H
Int J Geriatr Psychiatry; 2017 Dec; 32(12):e107-e115. PubMed ID: 28055139
[TBL] [Abstract][Full Text] [Related]
16. Use of proton pump inhibitors and risk of osteoporosis-related fractures.
Targownik LE; Lix LM; Metge CJ; Prior HJ; Leung S; Leslie WD
CMAJ; 2008 Aug; 179(4):319-26. PubMed ID: 18695179
[TBL] [Abstract][Full Text] [Related]
17. Association between proton pump inhibitor use and risk of fracture: A population-based case-control study.
Kim JJ; Jang EJ; Park J; Sohn HS
PLoS One; 2020; 15(7):e0235163. PubMed ID: 32730257
[TBL] [Abstract][Full Text] [Related]
18. Risk of Hip Fracture in Benzodiazepine Users With and Without Alzheimer Disease.
Saarelainen L; Tolppanen AM; Koponen M; Tanskanen A; Sund R; Tiihonen J; Hartikainen S; Taipale H
J Am Med Dir Assoc; 2017 Jan; 18(1):87.e15-87.e21. PubMed ID: 27847263
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the risk of osteoporotic fractures with proton pump inhibitor use and histamine-2 receptor antagonist therapy in elderly women: A nationwide population-based nested case-control study.
Park JH; Song YM; Jung JH; Han K
Bone; 2020 Jun; 135():115306. PubMed ID: 32126312
[TBL] [Abstract][Full Text] [Related]
20. Proton Pump Inhibitors, Histamine-2 Receptor Antagonists, and Hip Fracture Risk among Patients on Hemodialysis.
Vangala C; Niu J; Lenihan CR; Mitch WE; Navaneethan SD; Winkelmayer WC
Clin J Am Soc Nephrol; 2018 Oct; 13(10):1534-1541. PubMed ID: 30262672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
